Physician profile
Brandon D Woods
NPI 1164713749
$6,310.87
in general payments reported to CMS, 2019-2025
44 companies · $681 in 2025
The $681 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,435 · 2020: $1,139 · 2021: $1,552 · 2022: $440 · 2023: $603 · 2024: $461 · 2025: $681.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,595 · Consulting Fee: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,594.93 |
| Consulting Fee | $150.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $1,492.11 | 2019-2023 | Tysabri |
| Abbvie INC. | $1,124.93 | 2021-2025 | Botox, Ubrelvy, Qulipta |
| Ucb, INC. | $579.00 | 2019-2025 | Nayzilam |
| Argenx US, INC. | $485.85 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
| Allergan, INC. | $456.44 | 2019-2021 | |
| Pfizer INC. | $337.00 | 2023-2025 | |
| Lilly USA, LLC | $244.34 | 2019-2025 | Jardiance, Emgality, Reyvow |
| Novo Nordisk INC | $220.45 | 2019-2024 | Wegovy |
| Amgen INC. | $213.87 | 2019-2023 | Prolia, Evenity |
| Livanova USA, INC. | $149.88 | 2019-2025 | Vns Therapy Sentiva Model 1000 Generator |
| Bausch Health US, LLC | $119.28 | 2019 | |
| Upsher-Smith Laboratories LLC | $92.46 | 2019-2021 | |
| Eisai INC. | $75.94 | 2019-2021 | |
| Greenwich Biosciences, INC. | $64.86 | 2019 | |
| Janssen Pharmaceuticals, INC | $54.72 | 2022 |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandon Woods listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.